Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Fennec Pharmaceuticals Inc. (T.FRX) had Weighted-Average Shares Outstanding (Diluted) of 27.89M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-0.88M |
|
-- |
|
-- |
|
-- |
|
-0.26M |
|
-- |
|
-0.88M |
|
-0.88M |
|
-0.88M |
|
-0.88M |
|
-0.88M |
|
-0.88M |
|
-0.26M |
|
-0.24M |
|
27.89M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
27.89M |
-0.03 |
|
-0.03 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
67.86M |
|
-- |
|
-- |
|
-- |
|
74.05M |
|
-6.19M |
|
-6.19M |
|
-6.19M |
|
28.06M |
|
| Cash Flow Statement Financials | |
-8.97M |
|
-- |
|
2.51M |
|
36.69M |
|
30.23M |
|
-6.46M |
|
6.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.69 |
|
-- |
|
-- |
|
1.33 |
|
-4.03 |
|
94.70% |
|
-1.52% |
|
-1.52% |
|
-- |
|
-5.12% |
|
-5.12% |
|
-8.97M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.27 |
|
0.64 |
|
139.69 |
|
14.20% |
|
14.20% |
|
-1.30% |
|
-4.69% |
|
-0.22 |
|
-0.32 |
|
-0.32 |
|